116 related articles for article (PubMed ID: 32292123)
1. Oxygen Plasma Substrate and Specific Nanopattern Promote Early Differentiation of HepaRG Progenitors.
Morgan K; Bryans A; Brzeszczyński F; Samuel K; Treskes P; Brzeszczyńska J; Morley SD; Hayes PC; Gadegaard N; Nelson LJ; Plevris JN
Tissue Eng Part A; 2020 Oct; 26(19-20):1064-1076. PubMed ID: 32292123
[TBL] [Abstract][Full Text] [Related]
2. A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro.
Wang ZY; Li WJ; Li QG; Jing HS; Yuan TJ; Fu GB; Tang D; Zhang HD; Yan HX; Zhai B
Biomed Pharmacother; 2019 Aug; 116():109010. PubMed ID: 31136950
[TBL] [Abstract][Full Text] [Related]
3. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor.
Cerec V; Glaise D; Garnier D; Morosan S; Turlin B; Drenou B; Gripon P; Kremsdorf D; Guguen-Guillouzo C; Corlu A
Hepatology; 2007 Apr; 45(4):957-67. PubMed ID: 17393521
[TBL] [Abstract][Full Text] [Related]
4. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
[TBL] [Abstract][Full Text] [Related]
5. Development of a DsRed-expressing HepaRG cell line for real-time monitoring of hepatocyte-like cell differentiation by fluorescence imaging, with application in screening of novel geometric microstructured cell growth substrates.
Uta M; Sima LE; Hoffmann P; Dinca V; Branza-Nichita N
Biomed Microdevices; 2017 Mar; 19(1):3. PubMed ID: 28070697
[TBL] [Abstract][Full Text] [Related]
6. Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxide.
Hoekstra R; Nibourg GA; van der Hoeven TV; Plomer G; Seppen J; Ackermans MT; Camus S; Kulik W; van Gulik TM; Elferink RP; Chamuleau RA
Drug Metab Dispos; 2013 Mar; 41(3):562-7. PubMed ID: 23238784
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of the human liver progenitor cell line (HepaRG) on a microfluidic-based biochip.
Jang M; Kleber A; Ruckelshausen T; Betzholz R; Manz A
J Tissue Eng Regen Med; 2019 Mar; 13(3):482-494. PubMed ID: 30746894
[TBL] [Abstract][Full Text] [Related]
8. lnc-RHL, a novel long non-coding RNA required for the differentiation of hepatocytes from human bipotent progenitor cells.
Prabhakar B; Lee S; Bochanis A; He W; Manautou JE; Rasmussen TP
Cell Prolif; 2021 Feb; 54(2):e12978. PubMed ID: 33393114
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
[TBL] [Abstract][Full Text] [Related]
10. Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.
Nelson LJ; Morgan K; Treskes P; Samuel K; Henderson CJ; LeBled C; Homer N; Grant MH; Hayes PC; Plevris JN
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):30-37. PubMed ID: 27285124
[TBL] [Abstract][Full Text] [Related]
11. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism.
Rebelo SP; Costa R; Estrada M; Shevchenko V; Brito C; Alves PM
Arch Toxicol; 2015 Aug; 89(8):1347-58. PubMed ID: 25107451
[TBL] [Abstract][Full Text] [Related]
12. Hepatic differentiation of human pluripotent stem cells on human liver progenitor HepaRG-derived acellular matrix.
Kanninen LK; Porola P; Niklander J; Malinen MM; Corlu A; Guguen-Guillouzo C; Urtti A; Yliperttula ML; Lou YR
Exp Cell Res; 2016 Feb; 341(2):207-17. PubMed ID: 26854693
[TBL] [Abstract][Full Text] [Related]
13. Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures.
Jackson JP; Li L; Chamberlain ED; Wang H; Ferguson SS
Drug Metab Dispos; 2016 Sep; 44(9):1463-79. PubMed ID: 27338863
[TBL] [Abstract][Full Text] [Related]
14. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
15. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human.
Andersson TB; Kanebratt KP; Kenna JG
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):909-20. PubMed ID: 22568886
[TBL] [Abstract][Full Text] [Related]
16. Micropatterned Coculture With 3T3-J2 Fibroblasts Enhances Hepatic Functions and Drug Screening Utility of HepaRG Cells.
Ware BR; Liu JS; Monckton CP; Ballinger KR; Khetani SR
Toxicol Sci; 2021 Apr; 181(1):90-104. PubMed ID: 33590212
[TBL] [Abstract][Full Text] [Related]
17. DMSO and Its Role in Differentiation Impact Efficacy of Human Adenovirus (HAdV) Infection in HepaRG Cells.
Hofmann K; Hofmann S; Weigl F; Mai J; Schreiner S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675973
[TBL] [Abstract][Full Text] [Related]
18. Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells.
van der Mark VA; Rudi de Waart D; Shevchenko V; Elferink RP; Chamuleau RA; Hoekstra R
Drug Metab Dispos; 2017 Jan; 45(1):56-67. PubMed ID: 27780834
[TBL] [Abstract][Full Text] [Related]
19. The HepaRG cell line is suitable for bioartificial liver application.
Hoekstra R; Nibourg GA; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Lamers WH; Elferink RP; Chamuleau RA
Int J Biochem Cell Biol; 2011 Oct; 43(10):1483-9. PubMed ID: 21726661
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells.
Dubois-Pot-Schneider H; Aninat C; Kattler K; Fekir K; Jarnouen K; Cerec V; Glaise D; Salhab A; Gasparoni G; Takashi K; Ishida S; Walter J; Corlu A
Cells; 2022 Jul; 11(15):. PubMed ID: 35892596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
